Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis？

DOI: 10.2147/CMAR.S194523

Keywords: FLT3-ITD, NPM1, DNMT3A R882, allo-HSCT

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text